Evaluation of inactivated vaccines against equine group A rotaviruses by use of a suckling mouse model.

doi:10.1016/j.vaccine.2018.07.057

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Evaluation of inactivated vaccines against equine group A rotaviruses by use of a suckling mouse model.

Vaccine - 5 Sept 2018

Nemoto Manabu, Inagaki Mizuho, Tamura Norihisa, Bannai Hiroshi, Tsujimura Koji, Yamanaka Takashi, Kokado Hiroshi

Abstract excerpt

BACKGROUND: Equine group A rotaviruses (RVAs) cause diarrhea in suckling foals. The dominant RVAs circulating among horses worldwide, including Japan, are G3P[12] and/or G14P[12] genotypes. Inactivated vaccines containing a G3P[12] RVA are commercially available in some countries for prevention of diarrhea caused by equine RVAs. However, there is no reported evidence whether vaccines containing a G3P[12] RVA are...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Animals, Suckling
Share to Diarrhea
Share to Horse Diseases
Share to Horses

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Rotavirus

Share to Rotavirus Infections

Share to Rotavirus Vaccines

Share to Vaccines, Inactivated

Source

Open in PubMed

Identifiers

PMID: 30076106
DOI: 10.1016/j.vaccine.2018.07.057

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.